{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:34:06Z","timestamp":1791599646461,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:00:00Z","timestamp":1713052800000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1SC3GM130430-03"],"award-info":[{"award-number":["1SC3GM130430-03"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.neulet.2023.137237","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T15:30:55Z","timestamp":1681313455000},"page":"137237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The D3 receptor antagonist SR 21502 reduces cue-induced reinstatement of methamphetamine-seeking in rats"],"prefix":"10.1016","volume":"806","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6663-1169","authenticated-orcid":false,"given":"Robert","family":"Ranaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Timken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daleya","family":"Parasram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasmia","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Moukha-Chafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Augelli-Szafran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Streicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2023.137237_b0005","unstructured":"What is the scope of methamphetamine use in the United States?, (2022)."},{"key":"10.1016\/j.neulet.2023.137237_b0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/YCO.0000000000000168","article-title":"Global patterns of methamphetamine use","volume":"28","author":"Chomchai","year":"2015","journal-title":"Curr Opin Psychiatry."},{"key":"10.1016\/j.neulet.2023.137237_b0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(17)32893-3","article-title":"Medications for opioid use disorder: bridging the gap in care","volume":"391","author":"Volkow","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2023.137237_b0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jama.2018.8826","article-title":"Helping to End Addiction Over the Long-term: The Research Plan for the NIH HEAL Initiative","volume":"320","author":"Collins","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.neulet.2023.137237_b0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2013.261","article-title":"The development and maintenance of drug addiction, Neuropsychopharmacology : Official Publication of the American College of","volume":"39","author":"Wise","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neulet.2023.137237_b0030","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/10550490902925920","article-title":"Theories of addiction: methamphetamine users\u2019 explanations for continuing drug use and relapse","volume":"18","author":"Newton","year":"2009","journal-title":"Am J Addict."},{"key":"10.1016\/j.neulet.2023.137237_b0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0006-8993(90)90295-M","article-title":"Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine\u2013an in vivo dialysis study in freely moving rats","volume":"507","author":"Akimoto","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2023.137237_b0040","first-page":"312","article-title":"Release of dopamine via the human transporter","volume":"45","author":"Eshleman","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2023.137237_b0045","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1126\/science.249.4969.631","article-title":"Ice: A new dosage form of an old drug","volume":"249","author":"Cho","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neulet.2023.137237_b0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/FBP.0b013e328333a28d","article-title":"Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats","volume":"20","author":"Brennan","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neulet.2023.137237_b0055","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1369-1600.2010.00211.x","article-title":"The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access","volume":"15","author":"Orio","year":"2010","journal-title":"Addict. Biol."},{"issue":"7","key":"10.1016\/j.neulet.2023.137237_b0060","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1523\/JNEUROSCI.14-07-04130.1994","article-title":"Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats","volume":"14","author":"Gratton","year":"1994","journal-title":"J. Neurosci."},{"issue":"14","key":"10.1016\/j.neulet.2023.137237_b0065","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1523\/JNEUROSCI.22-14-06247.2002","article-title":"Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue","volume":"22","author":"Ito","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2023.137237_b0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neubiorev.2021.02.007","article-title":"Neurobiology of reward-related learning","volume":"124","author":"Galaj","year":"2021","journal-title":"Neurosci Biobehav Rev."},{"key":"10.1016\/j.neulet.2023.137237_b0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neubiorev.2018.03.020","article-title":"Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder","volume":"89","author":"Galaj","year":"2018","journal-title":"Neurosci Biobehav Rev."},{"key":"10.1016\/j.neulet.2023.137237_b0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0893-133X(98)00049-9","article-title":"Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects","volume":"20","author":"Peacock","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neulet.2023.137237_b0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00213-013-3254-y","article-title":"The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats","volume":"231","author":"Galaj","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2023.137237_b0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2015.09.011","article-title":"The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats","volume":"156","author":"Galaj","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neulet.2023.137237_b0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neulet.2014.03.055","article-title":"The novel dopamine D3 receptor antagonist, SR 21502, reduces cocaine conditioned place preference in rats","volume":"569","author":"Hachimine","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2023.137237_b0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drugalcdep.2015.11.030","article-title":"The dopamine D3 receptor antagonist, SR 21502, facilitates extinction of cocaine conditioned place preference","volume":"159","author":"Galaj","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neulet.2023.137237_b0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/0269881109358201","article-title":"PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats","volume":"25","author":"Higley","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neulet.2023.137237_b0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2014.09.026","article-title":"A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats","volume":"743","author":"Chen","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2023.137237_b0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/jpet.301.1.152","article-title":"Cardiovascular responses elicited by the \u201cbinge\u201d administration of methamphetamine","volume":"301","author":"Varner","year":"2002","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.neulet.2023.137237_b0120","doi-asserted-by":"crossref","unstructured":"Guide for the Care and Use of Laboratory Animals: Eighth Edition, National Academies Press, Washington, D.C., 2011. https:\/\/doi.org\/10.17226\/12910.","DOI":"10.17226\/12910"},{"issue":"9","key":"10.1016\/j.neulet.2023.137237_b0125","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00001756-200207020-00007","article-title":"Baclofen decreases methamphetamine self-administration in rats","volume":"13","author":"Ranaldi","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neulet.2023.137237_b0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pbb.2010.11.024","article-title":"Music and methamphetamine: conditioned cue-induced increases in locomotor activity and dopamine release in rats","volume":"98","author":"Polston","year":"2011","journal-title":"Pharmacol Biochem Behav."},{"key":"10.1016\/j.neulet.2023.137237_b0135","first-page":"1","article-title":"Dopamine and reward seeking: the role of ventral tegmental area","author":"Ranaldi","year":"2014","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neulet.2023.137237_b0140","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1124\/jpet.115.224121","article-title":"Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs, The","volume":"354","author":"Appel","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023001945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023001945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:01:38Z","timestamp":1736348498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394023001945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":28,"alternative-id":["S0304394023001945"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137237","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The D3 receptor antagonist SR 21502 reduces cue-induced reinstatement of methamphetamine-seeking in rats","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"137237"}}